GLP-1R was only present in cells, a finding similar to some reports, 45, 46 however, different from others, which reported the GLP-1R also in cells
When to Be Concerned: Malnutrition vs
However, this effect is not universal and shouldnt be the primary reason for taking the medication
The answers an individual provides to the Rae Rx assessment consequently determine if the individual is screened out of eligibility for GLP-1 medication, and an LocumTele clinician will meet with an individual after checkout to determine if they qualify for a prescription
Key takeaways Retatrutide is still being studied, so there is no FDA-approved dosing schedule yet
Taketa T, Correa AM, Suzuki A, Blum MA, Lee JE, Welsh J, Lin SH, Maru D, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Swisher S , Hofstetter WL, Ajani JA